Reticulon 4 receptor-like 2, often identified as RTN4RL2, is a protein that is implicated in various cellular processes. The exact function of RTN4RL2 is still under investigation, but it is believed to play a role in neuronal development and function. The reticulon family, to which RTN4RL2 belongs, is known to be involved in shaping the endoplasmic reticulum (ER) into tubules and maintaining the ER structure. The ER is an essential organelle in cells responsible for protein synthesis, folding, modification, and transport. Proper ER structure and function are critical for cellular health and homeostasis. Moreover, given its potential role in neuronal function, RTN4RL2 might also have implications in synapse formation, axon guidance, or neurotransmitter release.
Inhibitors of RTN4RL2 are chemical compounds that modulate the activity or expression of this protein. By targeting RTN4RL2, these inhibitors can potentially alter ER structure and dynamics. Given the protein's suspected role in neuronal function, its inhibitors might also impact neuronal development or synaptic activity. By inhibiting RTN4RL2, there might be alterations in the ER's ability to process proteins, which could lead to an accumulation of misfolded proteins, a condition detrimental to cell health. On the other hand, in the neuronal context, modulating RTN4RL2's function might influence neural connectivity or plasticity. Investigating the inhibitors of RTN4RL2 allows scientists to delve deeper into understanding the protein's role in the cell and to unravel the broader implications of its modulation in cellular and physiological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Known to disrupt ER to Golgi transport, which might impact reticulon functions. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Elevates intracellular calcium levels and can disrupt ER functions. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation in the ER which might affect proteins associated with the ER. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Disrupts intracellular trafficking and might impact reticulon-related processes. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $112.00 $199.00 $347.00 $683.00 $1336.00 $5722.00 | 12 | |
Inhibits ER-associated protein degradation which might affect reticulon proteins. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor which could affect degradation of ER-associated proteins. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
ATP-competitive p97 inhibitor, influencing ER-associated degradation. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $158.00 $306.00 $1186.00 | 9 | |
A fatty acid synthase inhibitor, which might affect lipid-associated processes in the ER. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3 kinase inhibitor which could influence multiple cellular pathways, including those in the ER. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3 kinase inhibitor, potentially influencing pathways related to reticulon proteins. | ||||||